title: Reduction of bone mass in women after bone marrow transplantation.
abstract: Osteoporosis is a common disease among patients undergoing transplantation. Its prevalence and complications have been well described in solid organ recipients, especially kidney, liver, and heart. However, studies in bone marrow transplantation (BMT) are scarce. Among the mechanisms invoked in the pathogenesis of BMT osteoporosis are the baseline disease, the use of immunosuppressive drugs and, more remarkably, secondary hypogonadism. We present a study of 27 women who underwent BMT, all of them suffering ovarian failure. We studied different biochemical markers of bone formation/resorption and also evaluated the presence of osteopenia/osteoporosis by dual energy X-ray absorptiometry (DXA) of the lumbar spine. Osteopenia was observed in nine patients (33%) and osteoporosis in another five (18%), according to the World Health Organization criteria. We also detected a subgroup showing elevation of several bone turnover biochemical markers, indicating high osseous remodeling. A remarkable increase in urine hydroxyproline/creatinine was detected in 95% of cases, although an explanation is lacking. We outline a reasonable therapeutic approach for osteoporosis in BMT emphasizing the need to monitor these patients after transplantation.
authors.affiliation: Rheumatology Section, Hospital Universitario de La Princesa, C/Diego de León 62, 28006 Madrid, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Castañeda
authors.forename: L
authors.initials: L
authors.lastname: Carmona
authors.forename: I
authors.initials: I
authors.lastname: Carvajal
authors.forename: R
authors.initials: R
authors.lastname: Arranz
authors.forename: A
authors.initials: A
authors.lastname: Díaz
authors.forename: A
authors.initials: A
authors.lastname: García-Vadillo
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology; D016026:Bone Marrow Transplantation; D001862:Bone Resorption / Q000209:etiology / Q000378:metabolism; D003404:Creatinine / Q000652:urine; D003430:Cross-Sectional Studies; D005260:Female; D019337:Hematologic Neoplasms / Q000628:therapy; D006728:Hormones / Q000097:blood; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007677:Kidney Function Tests; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008875:Middle Aged; D008903:Minerals / Q000097:blood; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism; D015663:Osteoporosis, Postmenopausal / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D016649:Primary Ovarian Insufficiency / Q000150:complications* / Q000209:etiology; D011877:Radionuclide Imaging; D012307:Risk Factors; D019172:Transplantation Conditioning / Q000009:adverse effects*
chemical_list: D015415:Biomarkers; D006728:Hormones; D007166:Immunosuppressive Agents; D008903:Minerals; D003404:Creatinine; D006909:Hydroxyproline